chr15-63327500-G-GT
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001218.5(CA12):c.908-268_908-267insA variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.30 ( 6004 hom., cov: 0)
Consequence
CA12
NM_001218.5 intron
NM_001218.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.887
Genes affected
CA12 (HGNC:1371): (carbonic anhydrase 12) Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. This gene product is a type I membrane protein that is highly expressed in normal tissues, such as kidney, colon and pancreas, and has been found to be overexpressed in 10% of clear cell renal carcinomas. Three transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 15-63327500-G-GT is Benign according to our data. Variant chr15-63327500-G-GT is described in ClinVar as [Benign]. Clinvar id is 1278122.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.391 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CA12 | NM_001218.5 | c.908-268_908-267insA | intron_variant | ENST00000178638.8 | |||
LOC124903506 | XR_007064676.1 | n.767+8762dup | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CA12 | ENST00000178638.8 | c.908-268_908-267insA | intron_variant | 1 | NM_001218.5 | A1 | |||
CA12 | ENST00000344366.7 | c.875-268_875-267insA | intron_variant | 1 | P4 | ||||
CA12 | ENST00000422263.2 | c.695-268_695-267insA | intron_variant | 2 | |||||
CA12 | ENST00000560666.1 | n.118-268_118-267insA | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.296 AC: 41497AN: 140226Hom.: 6004 Cov.: 0
GnomAD3 genomes
AF:
AC:
41497
AN:
140226
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.296 AC: 41500AN: 140244Hom.: 6004 Cov.: 0 AF XY: 0.293 AC XY: 19858AN XY: 67810
GnomAD4 genome
AF:
AC:
41500
AN:
140244
Hom.:
Cov.:
0
AF XY:
AC XY:
19858
AN XY:
67810
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at